# OnCo record rolapitant (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rolapitant/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rolapitant" ;
  schema:name "Rolapitant"@en ;
  schema:alternateName "Varuby"@en, "Varubi" ;
  schema:description "Rolapitant (Varubi) is a long-lasting anti-sickness tablet taken once before chemotherapy, alongside a 5-HT3 blocker and dexamethasone, to prevent nausea and vomiting in the days after treatment."@en ;
  schema:url <https://onco.cc/drugs/rolapitant/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Rolapitant> ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)00034-0>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8670c3cf-82d9-466d-be49-de33d8c8742b>, <https://www.cancer.gov/about-cancer/treatment/drugs/rolapitanthydrochloride> ;
  onco:status "approved" ;
  onco:tag "nci-list", "supportive" ;
  onco:modality "Neurokinin-1 receptor antagonist (antiemetic)" ;
  onco:approval "US 2015: Prevention of delayed nausea and vomiting with emetogenic chemotherapy, in combination with other antiemetics" ;
  onco:related <https://onco.cc/drugs/aprepitant/>, <https://onco.cc/drugs/netupitant-palonosetron/> ;
  onco:technologies <https://onco.cc/technologies/antiemetic-therapy/> ;
  onco:companies <https://onco.cc/companies/tersera-therapeutics/> ;
  onco:trials <https://onco.cc/trials/ts-p04834/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-rolapitant-study-3-schwartzberg-lancet-oncol-2015/> .